DANAHER CORP /DE/ DHR

Latest FY: 2025 Healthcare Diagnostics & Research
Market Price $202.41
Market Cap $144.32B
P/E Ratio 40.08
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑2.9% YoY
$24.57B
3-Yr CAGR: -7.9%
Net Income ↓-7.3% YoY
$3.61B
Net Margin: 14.7%
Free Cash Flow ↓-0.7% YoY
$5.26B
FCF Yield: 3.64%
EPS (Diluted) ↓-4.5% YoY
$5.05
Basic: $5.07
Return on Equity Efficiency
6.9%
ROA: 4.3%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (DHR)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $16,882.4M $9,334.6M $2,553.7M $3.24 $3,521.8M $2,932.2M
FY 2017 $18,329.7M +8.6% $10,192.5M $2,492.1M -2.4% $3.13 -3.3% $3,477.8M $2,858.2M -2.5%
FY 2018 $19,893.0M +8.5% $11,107.1M $2,650.9M +6.4% $3.32 +5.9% $4,022.0M $3,366.3M +17.8%
FY 2019 $17,911.1M -10.0% $9,983.7M $3,008.2M +13.5% $3.59 +8.3% $3,951.6M $3,316.1M -1.5%
FY 2020 $22,284.0M +24.4% $12,475.0M $3,646.0M +21.2% $4.34 +20.7% $6,208.0M $5,417.0M +63.4%
FY 2021 $29,453.0M +32.2% $17,952.0M $6,433.0M +76.4% $7.63 +76.1% $8,358.0M $7,064.0M +30.4%
FY 2022 $31,471.0M +6.9% $18,949.0M $7,209.0M +12.1% $8.56 +12.2% $8,519.0M $7,367.0M +4.3%
FY 2023 $23,890.0M -24.1% $14,034.0M $4,764.0M -33.9% $6.38 -25.5% $7,164.0M $5,781.0M -21.5%
FY 2024 $23,875.0M -0.1% $14,206.0M $3,899.0M -18.2% $5.29 -17.1% $6,688.0M $5,296.0M -8.4%
FY 2025 $24,568.0M +2.9% $14,523.0M $3,614.0M -7.3% $5.05 -4.5% $6,416.0M $5,260.0M -0.7%
$

Valuation

Market Price $202.41
Market Cap $144.32B
Enterprise Value $142.83B
P/E Ratio 40.08
P/B Ratio 2.73
FCF Yield 3.64%
Dividend Yield N/A
Shares Outstanding 707,770,600
%

Profitability & Margins

Gross Margin 59.11%
Operating Margin 19.09%
Net Margin 14.71%
Return on Equity (ROE) 6.88%
Return on Assets (ROA) 4.33%
Asset Turnover 0.29x
Revenue 3-Yr CAGR -7.92%
🛡️

Financial Health & Liquidity

Current Ratio 0.35
Cash Ratio 4.01
Debt / Equity 0.351
Debt / Assets 0.221
Cash & Equivalents $19.91B
Total Debt $18.42B
Book Value / Share $74.22
💧

Cash Flow Efficiency

Operating Cash Flow $6.42B
Capital Expenditures (CapEx) $1.16B
Free Cash Flow $5.26B
OCF / Revenue 26.12%
FCF / Revenue 21.41%
FCF 3-Yr CAGR -10.62%
🏷️

Per Share Metrics

EPS (Diluted) $5.05
EPS (Basic) $5.07
Dividends / Share N/A
Book Value / Share $74.22
EPS YoY Growth -4.54%
🏛️

Balance Sheet (FY 2025)

Total Assets $83.46B
Total Liabilities $83.46B
Stockholders' Equity $52.53B
Current Assets $1.74B
Current Liabilities $4.96B